Search results for "Cirrhosis"
In compensated cirrhosis with portal hypertension, beta-blockers reduced a composite of decompensation or death
The trial results cannot be generalized to all patients with cirrhosis, and future trials should look at whether similar effects could be achieved simply by limiting salt intake, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2019/08/23/10.htm
23 Aug 2019
Spotlight on cirrhosis
Patients with cirrhosis were the focus of several recent studies, which reviewed the evidence behind nutritional assessment, calculated the cost-effectiveness of hepatocellular carcinoma screening, and estimated the prevalence of nonalcoholic steatohepatitis-associated cirrhosis.
https://gastroenterology.acponline.org/archives/2017/02/24/5.htm
24 Feb 2017
MKSAP quiz: HCV-related cirrhosis with decompensation
This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.
https://gastroenterology.acponline.org/archives/2019/03/22/4.htm
22 Mar 2019
EHR-based clinical pathway may improve care for advanced liver disease in type 2 diabetes
A trial in Asia found that automated calculation of fibrosis scores and electronic reminder messages to clinicians increased referrals of patients with abnormal results to appropriate care, although subsequent diagnosis of advanced liver disease was uncommon.
https://gastroenterology.acponline.org/archives/2023/08/25/3.htm
25 Aug 2023
Pioglitazone associated with improved advanced fibrosis in patients with NASH
A recent meta-analysis looked at randomized clinical trials that examined the effect of thiazolidinediones on liver histology in patients with nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2017/03/24/1.htm
24 Mar 2017
Sepsis-3 better than SIRS in patients with cirrhosis and infection
Compared to systemic inflammatory response syndrome (SIRS) criteria, both Sepsis-3 criteria and the quick Sequential Organ Failure Assessment (qSOFA) tool had significantly better discrimination for in-hospital mortality.
https://gastroenterology.acponline.org/archives/2017/09/22/2.htm
22 Sep 2017
Clinical practice update offers recommendations on noninvasive testing for NAFLD
Noninvasive tests have the potential to significantly enhance the care of patients with nonalcoholic fatty liver disease (NAFLD) by improving detection of advanced fibrosis, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/08/25/1.htm
25 Aug 2023
NASH management conflicts with guidelines in real-world setting, study finds
Researchers sought to learn how patient characteristics vary by stages of liver scarring and how U.S. physicians manage nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2023/05/26/2.htm
26 May 2023
Noninvasive methods as good as biopsy for NAFLD prognosis, meta-analysis finds
An analysis of patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) compared the prognostic value of liver stiffness measured by vibration-controlled transient elastography, fibrosis-4 index, and NAFLD fibrosis score.
https://gastroenterology.acponline.org/archives/2023/06/23/1.htm
23 Jun 2023
ID, liver societies update guidance for HCV testing, management
Major changes to guidance on hepatitis C virus (HCV) include an emphasis on universal screening, new recommendations for managing incomplete treatment adherence, and expansion of treatment eligibility, among others.
https://gastroenterology.acponline.org/archives/2023/06/23/6.htm
23 Jun 2023